Stocks

Ginkgo Bioworks Holdings DNA

Health care sectorNYSE

What to see in Ginkgo Bioworks Holdings now

Who bought more than 5%?7.7%

BlackRock holds 7.7% · +1.2pp on the report before

Filed 07/30
Is Wall Street adding or cutting?+8

183 13F filers hold it · +8 against the quarter before · shares held +11.9%

Holdings of 06/30
Is stock about to come to market?$51.4K

$51.4K of planned sales filed in 30 days · under 0.1% of the units outstanding

Filed 09/17

Company

Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
Headquarters
Boston, Massachusetts
Fiscal year end
12/31
Next earnings
11/04, estimated
  • BlackRock holds 7.7% · +1.2pp on the report beforeFiled 07/30
  • 183 13F filers hold it · +8 against the quarter before · shares held +11.9%Holdings of 06/30

Funds

13F filers: 183 · +8 since the quarter before · 06/30 holdings

Famous funds that held Ginkgo Bioworks Holdings in their latest 13F report.

FundValueSince the quarter before
Viking Global InvestorsGinkgo Bioworks Holdings DNA · 06/30 holdings$35.4MNo change
Mirae Asset Global ETFS HoldingsGinkgo Bioworks Holdings DNA · 06/30 holdings$217.4KNo quarter before
All tracked funds

5% stakes

Holder
BlackRock07/307.7%4,122,510 sh+1.2pp
Vanguard Group03/260%0 sh−5.1pp
Vanguard Group25/07/295.13%2,381,115 sh+0.7pp
BlackRock25/07/176.5%3,001,643 shFirst report
Reshma P. Shetty25/02/149.5%4,716,084 shNo earlier report
All 5% stake reports on Ginkgo Bioworks Holdings

26-week trading